Get started
Gilead Sciences, Inc. 1.65% 01-OCT-2030Gilead Sciences, Inc. 1.65% 01-OCT-2030Gilead Sciences, Inc. 1.65% 01-OCT-2030

Gilead Sciences, Inc. 1.65% 01-OCT-2030

No trades
See on Supercharts
Overview
Analysis News

GILD5050565 chart


Full chart

Key terms


Outstanding amount
‪1.00 B‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
1.65% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.34%
Maturity date
Oct 1, 2030
Term to maturity
5 years

About Gilead Sciences, Inc. 1.65% 01-OCT-2030


Issuer
Gilead Sciences, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
gilead.com
Issue date
Sep 30, 2020
FIGI
BBG00XKL4C07
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

GILD5050565 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

GILD5050565 news